Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Debt Ratio (2017 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Debt Ratio for 11 consecutive years, with 0.21 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 13.39% to 0.21 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.21 through Dec 2025, down 13.39% year-over-year, with the annual reading at 0.21 for FY2025, 13.39% down from the prior year.
  • Debt Ratio hit 0.21 in Q4 2025 for Ani Pharmaceuticals, down from 0.22 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.43 in Q3 2021 to a low of 0.21 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.33 across 5 years, with a median of 0.34 in 2023.
  • Biggest five-year swings in Debt Ratio: increased 5.67% in 2021 and later dropped 24.36% in 2025.
  • Year by year, Debt Ratio stood at 0.37 in 2021, then increased by 0.91% to 0.38 in 2022, then dropped by 15.96% to 0.32 in 2023, then decreased by 21.55% to 0.25 in 2024, then dropped by 13.39% to 0.21 in 2025.
  • Business Quant data shows Debt Ratio for ANIP at 0.21 in Q4 2025, 0.22 in Q3 2025, and 0.23 in Q2 2025.